IRWD is trading 5.3% up today at $4.35 amid a broadly positive U.S. equity session.
- The move appears aligned with the overall market trend rather than driven by fresh, company-specific news or catalysts for Ironwood Pharmaceuticals.
- Major indices are showing significant strength, with the S&P 500 and Nasdaq each gaining more than 1% during the session.